PHD.MEDLEG
ActiveSummary
PHD.MEDLEG has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €404,884 and a net result of €89,055. Equity is growing by about 5.3% per year across the filed financial years. Its solvency ranks better than 90% of 20,649 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
12-12
Gazette deed
Reappointment: Philippe DEWAELE (sole director)Amendment of the articles · Capital conversion · Reserve release10 facts ▸
- General meeting, 08-12-2023
- Other provision, “applicabilité impérative CSA, article 39,2-1 deuxième alinéa loi du 23-03-2019 introduisant CSA” (deed in French)
- Amendment of the articles (2 times)
- Capital conversion, 31-12-2022, “compte de capitaux propres statutairement indisponibles” (deed in French)
- Reserve release, “fonds libérés, rendre immédiatement disponibles pour distribution future” (deed in French)
- Capital
- Director reappointment, Philippe DEWAELE (sole director)
- Registered office clause, “Région Wallonne, maintenu” (deed in French)
- Other provision, “coordonnées électroniques” (deed in French)
- Power of attorney, Emmanuel NIZET
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.